Upregulation of Loxl3 with leptin treatment of primary chondrocytes from affected rat knees with increased apoptosis and concomitant suppression of autophagy corroborated LOXL3 involvement in osteoarthritis and point to it as a potential therapeutic target in this disease [39]. This evidence concerns the gene LOXL3 and osteoarthritis.